单位:[1]Department of Pulmonary and Critical Care Medicine, Sinopharm Tongmei General Hospital, Datong, China [2]China-Japan Friendship Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China [3]Department of Emergency, Chinese PLA General Hospital-Fourth Medical Center, Beijing, China [4]China-Japan Friendship Hospital, National Clinical Research Center for Respiratory Diseases, Clinical Center for Pulmonary Infections, Capital Medical University, Beijing, China
- OBJECTIVE: COPD is a complex re-spiratory disease characterized by chronic airway inflammation and the airflow limitations are not ful-ly reversible due to the combination of genetic and environmental factors. Genetic factors such as poly-morphisms, may affect the susceptibility of COPD. In the present study, we examined the association between the polymorphisms of three genes and COPD risk in a Chinese Han population.PATIENTS AND METHODS: A total of 375 COPD patients and 284 control subjects were recruited from November 2018 to June 2021. Data on demo-graphic basic information, smoking status, history of coal dust exposure, and peripheral blood were collected from subjects of two groups. Three poly-morphisms (NLRP3 rs1539019, LAMB1 rs4320486, IL-6 rs1800796) were analyzed. Logistic analysis was used to evaluate the genetic contribution of selected SNPs to COPD susceptibility.RESULTS: The AC genotype of NLRP3 rs1539019 significantly decreased COPD risk compared with CC genotype (adjusted OR = 0.508, 95% CI 0.336-0.767). In the stratification analyses, the AC genotype signifi-cantly decreased the risk of COPD in subjects aged 60 and over (p=0.005; adjusted OR = 0.553; 95% CI 0.366-0.835) with current smoking status (p=0.002; adjusted OR = 0.419; 95% CI 0.240-0.732) when com-pared with AA+CC genotype. Moreover, a significant-ly decreased risk for GOLD III COPD was found in genotype AC of NLRP3 rs1539019 (p=0.006; adjust-ed OR = 0.502; 95% CI 0.306-0.822).CONCLUSIONS: Our present study revealed that the genotype AC of NLRP3 rs1539019 is related to a decreased risk of COPD in a Chinese Han popula-tion, a large-sample, multi-center, multi-ethnic study is needed to further confirm our study.
基金:
Sinopharm Tongmei Gen-eral Hospital, Science and Technology Research Projects [2019002]
第一作者单位:[1]Department of Pulmonary and Critical Care Medicine, Sinopharm Tongmei General Hospital, Datong, China [2]China-Japan Friendship Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
通讯作者:
通讯机构:[1]Department of Pulmonary and Critical Care Medicine, Sinopharm Tongmei General Hospital, Datong, China [2]China-Japan Friendship Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
推荐引用方式(GB/T 7714):
Hou Z. -f.,Yuan Z. -h.,Chang K.,et al.NLRP3 rs1539019 is significantly associated with chronic obstructive pulmonary disease in a Chinese Han population: a case-control study[J].EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES.2022,26(16):5821-5828.
APA:
Hou, Z. -f.,Yuan, Z. -h.,Chang, K.,Cao, Y. -h.,Guan, F. -x.&Gao, Y..(2022).NLRP3 rs1539019 is significantly associated with chronic obstructive pulmonary disease in a Chinese Han population: a case-control study.EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES,26,(16)
MLA:
Hou, Z. -f.,et al."NLRP3 rs1539019 is significantly associated with chronic obstructive pulmonary disease in a Chinese Han population: a case-control study".EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 26..16(2022):5821-5828